Related Experiment Video
Updated: Sep 3, 2025

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
Published on: June 10, 2025
Artificial intelligence for prostate MRI: open datasets, available applications, and grand challenges.
Mohammed R S Sunoqrot1,2, Anindo Saha3, Matin Hosseinzadeh3
1Department of Circulation and Medical Imaging, NTNU-Norwegian University of Science and Technology, 7030, Trondheim, Norway. mohammed.sunoqrot@ntnu.no.
Artificial intelligence (AI) is emerging in prostate cancer (PCa) diagnosis using MRI, offering workflow efficiencies. Further validation on diverse datasets is crucial for broader clinical adoption and exploring AI in other PCa stages.
Area of Science:
- Medical Imaging
- Artificial Intelligence
- Oncology
Background:
- Artificial intelligence (AI) is increasingly utilized in prostate cancer (PCa) detection and characterization via magnetic resonance imaging (MRI).
- AI-assisted reading of prostate MRI shows potential for reducing radiologist workflow times.
- Existing open datasets comprise over 3,300 multi-vendor prostate MRI cases, varying in acquisition parameters and annotation quality.
Purpose of the Study:
- To review the current landscape of AI applications in prostate MRI.
- To assess the available open datasets for AI development and validation.
- To identify future research directions for AI in prostate cancer management.
Main Methods:
- Analysis of publicly available prostate MRI datasets (approx. 253 GB, 3,369 cases).
- Consideration of seven grand challenges and commercial AI applications from eleven vendors.
- Review of studies focusing on AI for prostate cancer detection, classification, and segmentation.
Main Results:
- Prostate MRI datasets vary significantly in quality and annotation, requiring careful usage.
- AI shows feasibility for workflow reduction in prostate cancer detection and classification.
- Limited prospective validation exists, highlighting the need for large-scale, multi-institutional studies.
Conclusions:
- AI holds promise for clinical integration in prostate cancer MRI, particularly for detection and characterization.
- The heterogeneity of current open datasets necessitates rigorous validation strategies.
- Future AI research should expand beyond detection to encompass prognosis, follow-up, and treatment planning in prostate cancer.
Related Concept Videos
Imaging Studies IV: Magnetic Resonance Imaging
Magnetic Resonance Imaging

